The Optimal Scope of FDA Regulation of Genetic Tests: Meeting Challenges and Keeping Promises. The Optimal Scope of FDA Regulation of Genetic Tests: Meeting Challenges and Keeping Promises.

The Optimal Scope of FDA Regulation of Genetic Tests: Meeting Challenges and Keeping Promises‪.‬

Harvard Journal of Law & Technology 2007, Spring, 20, 2

Harvard Journal of Law & Technology
    • 2,99 €
    • 2,99 €

Description de l’éditeur

I. INTRODUCTION With the completion of the Human Genome Project and the advent of increasingly sophisticated genetic technologies, the promise that genetic advances will revolutionize medicine appears closer than ever. Soon, tests will function as medical crystal balls, forecasting risks of disease years into the future based on genetic variations. Medical care might soon benefit from tests that accurately predict the risk of common diseases with complex etiologies, such as cancers, Parkinson's disease, or Alzheimer's disease. (1)

GENRE
Professionnel et technique
SORTIE
2007
22 mars
LANGUE
EN
Anglais
LONGUEUR
38
Pages
ÉDITIONS
Harvard Law School, Harvard Journal of Law & Technology
TAILLE
231,8
Ko

Plus de livres similaires

Promoting Safe and Effective Genetic Tests in the United States: Work of the Task Force on Genetic Testing (Clinical Chemistry Forum) Promoting Safe and Effective Genetic Tests in the United States: Work of the Task Force on Genetic Testing (Clinical Chemistry Forum)
Promoting Safe and Effective Genetic Tests in the United States: Work of the Task Force on Genetic Testing (Clinical Chemistry Forum)
1999
An Evidence Framework for Genetic Testing An Evidence Framework for Genetic Testing
An Evidence Framework for Genetic Testing
2017
Ensuring Accurate Molecular Genetic Testing (Editorial) Ensuring Accurate Molecular Genetic Testing (Editorial)
Ensuring Accurate Molecular Genetic Testing (Editorial)
1998
Practical Handbook of Clinical Investigation Practical Handbook of Clinical Investigation
Practical Handbook of Clinical Investigation
2016
The Role of the Study Director in Nonclinical Studies The Role of the Study Director in Nonclinical Studies
The Role of the Study Director in Nonclinical Studies
2014
The Role of Food and Drug Administration Regulation of in Vitro Diagnostic Devices--Applications to Genetics Testing (Clinical Chemistry Forum) The Role of Food and Drug Administration Regulation of in Vitro Diagnostic Devices--Applications to Genetics Testing (Clinical Chemistry Forum)
The Role of Food and Drug Administration Regulation of in Vitro Diagnostic Devices--Applications to Genetics Testing (Clinical Chemistry Forum)
1999

Plus de livres par Harvard Journal of Law & Technology

A Knot in the Eternal Golden Braid: Searching for Coherence in the Relationship Between Enablement, Anticipation, And Obviousness. A Knot in the Eternal Golden Braid: Searching for Coherence in the Relationship Between Enablement, Anticipation, And Obviousness.
A Knot in the Eternal Golden Braid: Searching for Coherence in the Relationship Between Enablement, Anticipation, And Obviousness.
2010
Much Ado About Data Ownership. Much Ado About Data Ownership.
Much Ado About Data Ownership.
2011
The Wealth of Networks: How Social Production Transforms Markets and Freedom (Book Review) The Wealth of Networks: How Social Production Transforms Markets and Freedom (Book Review)
The Wealth of Networks: How Social Production Transforms Markets and Freedom (Book Review)
2006
Brand Spillovers. Brand Spillovers.
Brand Spillovers.
2009
Bad Faith in Cyberspace: Grounding Domain Name Theory in Trademark, Property, And Restitution. Bad Faith in Cyberspace: Grounding Domain Name Theory in Trademark, Property, And Restitution.
Bad Faith in Cyberspace: Grounding Domain Name Theory in Trademark, Property, And Restitution.
2010
Open Source Semiconductor Core Licensing. Open Source Semiconductor Core Licensing.
Open Source Semiconductor Core Licensing.
2011